An Immunological Hub of Excellence in Porto tailored to fulfil the ERA Priorities

Informazioni relative al progetto

ImmunoHUB

ID dell’accordo di sovvenzione: 951921

DOI 10.3030/951921

Data della firma CE 10 Giugno 2020

Data di avvio 1 Gennaio 2021

Data di completamento 31 Dicembre 2026

Finanziato da

• Establishing ‚ERA Chairs’

Costo totale € 2 475 826,25

Contributo UE € 2 475 826,25

Coordinato da

INSTITUTO DE BIOLOGIA MOLECULAR E CELULAR-IBMC
Portugal

Risultati finali

Websites, patent fillings, videos etc. (3)

Implementation of the ImmunoHUB seminar series and Annual Meeting
Communication Toolkit
Public Website

Documents, reports (1)

Report on the recruitment of the ERA Chair holder

Open Research Data Pilot (1)

Data Management Plan

Pubblicazioni

Peer reviewed articles (5)

Development of FluoAHRL: A Novel Synthetic Fluorescent Compound That Activates AHR and Potentiates Anti-Inflammatory T Regulatory Cells

Autori: Natalija Jonić, Ivan Koprivica, Christos M. Chatzigiannis, Antonis D. Tsiailanis, Stavroula G. Kyrkou, Eleftherios Paraskevas Tzakos, Aleksandar Pavić, Mirjana Dimitrijević, Andjelina Jovanović, Milan B. Jovanović, Sérgio Marinho, Inês Castro-Almeida, Vesna Otašević, Pedro Moura-Alves, Andreas G. Tzakos, Ivana Stojanović
Pubblicato in: Molecules, Numero 29, 2024, Pagina/e 2988, ISSN 1420-3049
Editore: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/molecules29132988

Single-cell profiling of MC1R-inhibited melanocytes

Autori: H. Matthew Berns, Dawn E. Watkins-Chow, Sizhu Lu, Pakavarin Louphrasitthiphol, Tongwu Zhang, Kevin M. Brown, Pedro Moura-Alves, Colin R. Goding, William J. Pavan
Pubblicato in: Pigment Cell & Melanoma, Numero 37, 2024, Pagina/e 291-308, ISSN 1755-1471
Editore: Basil Blackwell
DOI: 10.1111/pcmr.13141

The Highly Potent AhR Agonist Picoberin Modulates Hh-Dependent Osteoblast Differentiation

Autori: Jana Flegel, Saad Shaaban, Zhi Jun Jia, Britta Schulte, Yilong Lian, Adrian Krzyzanowski, Malte Metz, Tabea Schneidewind, Fabian Wesseler, Anke Flegel, Alisa Reich, Alexandra Brause, Gang Xue, Minghao Zhang, Lara Dötsch, Isabelle D. Stender, Jan-Erik Hoffmann, Rebecca Scheel, Petra Janning, Fraydoon Rastinejad, Dennis Schade, Carsten Strohmann, Andrey P. Antonchick, Sonja Sievers, Pedro Moura-Alv
Pubblicato in: Journal of Medicinal Chemistry, Numero 65, 2022, Pagina/e 16268–16289, ISSN 0022-2623
Editore: American Chemical Society
DOI: 10.1021/acs.jmedchem.2c00956

Detection of Neutralizing Antibodies in COVID-19 Patients from Steve Biko Academic Hospital Complex: A Pilot Study

Autori: Mankgopo Kgatle, Joseph Musonda Chalwe, Donald van der Westhuizen, Shuting Xu, Botle Precious Damane, Precious Mathebela, Veronica Ueckermann, Simnikiwe Mayaphi, Hosana Gomes Rodrigues, Pedro Moura-Alves, Honest Ndlovu, Yonwaba Mzizi, Lusanda Zongo, Henry Hairwadzi, Mariza Vorster, Jan Rijn Zeevaart, Mike Sathekge
Pubblicato in: COVID, Numero 3, 2023, Pagina/e 999-1010, ISSN 2673-8112
Editore: MDPI
DOI: 10.3390/covid3070072

Targeting the aryl hydrocarbon receptor by gut phenolic metabolites: A strategy towards gut inflammation

Autori: Catarina J.G. Pinto, María Ángeles Ávila-Gálvez, Yilong Lian, Pedro Moura-Alves, Cláudia Nunes dos Santos
Pubblicato in: Redox Biology, Numero 61, 2023, ISSN 2213-2317
Editore: Elsevier BV
DOI: 10.1016/j.redox.2023.102622